Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Vanguard's "How America Saves" report analyzes U.S. retirement trends, focusing on 401(k) plans, including automatic enrollment and contribution rates.
Amazon says it had its best Prime Day sales event ever this week with $14.2 billion spent online on Tuesday and Wednesday, up 11% compared to last year.